The Institute of Neurosciences, Mental Health and Addiction (INMHA) supports research on the functioning and disorders of the brain, the spinal cord, the sensory and motor systems, and the mind. The burden of disease in terms of the social, economic and health care costs associated with these disorders and related illnesses are staggering and there are indications that the number of people affected either directly or indirectly will continue to increase in the years to come.

The INMHA is a unique institute because, based on recent discoveries, it has been designed to address all aspects of research dealing with Brain-Mind relationships inclusive of the four pillars of the CIHR, which are:

  • biomedical
  • clinical
  • health services
  • population health research

It is a daunting endeavour, but the INMHA can transform this challenge into a unique opportunity for fostering innovation in our area of health research.

Who we are


INMHA supports research that enhances knowledge of the brain - mental health, neurological health, vision, hearing and cognitive functioning. Our goal is to reduce the burden of brain illness through prevention strategies, screening, diagnosis, treatment, support system and palliation. We will improve understanding of human thought and emotion, behaviour, sensation (sight, hearing, touch, taste, smell) perception, learning, and memory.


Well-supported, excellent, innovative and ethically responsible discovery science, encompassing all aspects of nervous system and mental health research and clinical translation that results in quality healthcare and respects the diversity of culture and values of all Canadians.


To enable cutting-edge Canadian-led research, clinical translation, innovation, and engagement that leads to new knowledge about the biological and sociocultural processes underlying neurologic, mental health and addiction disorders, and promotes optimal quality of life, health care, and outcomes.

Building on our international reputation

By developing and advocating our vision, we've created a unique and innovative research model. We are taking that vision to the world. Below is a list of major international initiatives we have had the privilege to undertake.

  • Advisory Board Focus Group on International Affairs
  • Research partnership agreement with Mexico on the study of psychiatry and neurology
  • Partnerships with the Washington, D.C.-based National Institutes of Health (NIH) and the Fogarty International Center (FIC) on various initiatives, including stigma and global health, tobacco, and brain research in developing countries
  • Numerous meetings with NIH institutes and other international partners, including the Society for Neuroscience (SfN), US-based organization which represents over 30,000 neuroscientists from around the world, including about 2,000 Canadians
  • Institute representation and participation in the Society for Neuroscience's annual meeting in Orlando in 2002
  • Publication of a highly distributed paper about INMHA and the Canadian experiment in TINS (Trends In Neurosciences)
  • Partnership negotiations with US-based NGOs: National Alliance for Autism Research, National Alliance for Research on Schizophrenia and Depression, Parkinson's Disease Foundation, and the Juvenile Diabetes Research Foundation
  • Participation in and presentations to national and international meetings of brain-related research groups, including the Society for Neuroscience, Collegium Internationale NeuroPsychopharmacologium (CINP), the International Brain Research Organization (IBRO), and the Association for Research in Vision and Ophthalmology (ARVO)
  • Collaboration with the World Health Organization (WHO) on issues related to mental health
  • Renewed membership at IBRO, allowing Canada to rejoin the important international organization that was incorporated in Ottawa in 1961
Date modified: